Company Filing History:
2 out of 1,217 
2 out of 9 Years Active: 1997-1998
Title: Louis Malspeis: Innovator in Cancer Treatment
Introduction
Louis Malspeis is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Malspeis has focused on developing derivatives that exhibit promising antitumor activity.
Latest Patents
Malspeis's latest patents include the development of brefeldin A derivatives and their utility in the treatment of cancer. These derivatives are characterized by a specific formula wherein one of R₁ and R₂ is H, while the other is a substituent group containing 1 to 12 carbon atoms with a basic nitrogen atom or a quaternary ammonium group, or a salt thereof. These innovative derivatives demonstrate good antitumor activity and can be administered to human patients without the complications associated with brefeldin A.
Career Highlights
Throughout his career, Malspeis has worked with esteemed organizations, including the United States of America as represented by the Department of Health and Starks Associates Inc. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations
Malspeis has collaborated with notable colleagues such as B Rao Vishnuvajjala and Jeffrey G Supko. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Louis Malspeis is a distinguished inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative approach to developing brefeldin A derivatives showcases his commitment to advancing medical science.